Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 15, 2019 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,357 | $0.25 | 92,608 |
| Jan 15, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 779 | $137.33 | 12,142 |
| Jan 31, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,784 | $0.25 | 99,392 |
| Feb 18, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,946 | $0.25 | 108,338 |
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,749 | $100.77 | 19,891 |
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | $98.46 | 28,479 |
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 16,337 | $137.33 | 12,142 |
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,749 | -- | -- |
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | -- | -- |
| Jan 15, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 809 | $95.15 | 11,333 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.